Tag archive for ‘Dror Ben-’
Jewish Business News On Monday, June 30th, 2014

RedHill Biopharma acquires Phase II oncology drug

– Mesupron,  which targets gastrointestinal and other cancers, has been licensed from Wilex. RedHill Biopharma Ltd. (Nasdaq: RDHL); TASE: RDHL) has expanded its late clinical-stage gastrointestinal-focused More...

Wordpress site Developed by Fixing WordPress Problems